Skip to main content
Equibles

MetLife Investment Management, LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1529735 Whippany, NJ
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$80,099
-$7,099 QoQ
Shares Held
15,257
+43.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 98 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. LFCR ranks #35 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 512,924 $26,877,217
2 UTHR
UNITED THERAPEUTICS Corp
 20,421 $11,064,710
3 NBIX
Neurocrine Biosciences Inc
 51,732 $8,718,911
4 ZTS
Zoetis Inc.
 108,947 $7,828,931
5 HIMS
Hims & Hers Health, Inc.
 224,462 $7,782,097
6 LNTH
Lantheus Holdings, Inc.
 68,281 $7,575,094
7 ELAN
Elanco Animal Health Inc
 240,384 $5,915,850
8 VTRS
Viatris Inc
 266,382 $4,230,146

All Filings in LFCR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,099 15,257
2025-12-31 $87,198 10,660
2025-09-30 $121,403 16,495
2025-06-30 $123,570 15,218
2025-03-31 $75,940 10,787
2024-12-31 $107,831 14,513
2023-03-31 $27,888 7,378
2022-12-31 $96,377 14,873
2022-09-30 $132,220 14,873
2022-06-30 $118,034 11,839
2022-03-31 $173,815 15,010
2021-12-31 $29,281 2,638
2021-09-30 $92,144 9,994
2020-12-31 $132,163 12,181
2020-09-30 $117,641 12,103
2020-06-30 $96,339 12,103
2020-03-31 $105,175 12,103